Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 238


The histone acetyltransferase hMOF promotes vascular invasion in hepatocellular carcinoma.

Poté N, Cros J, Laouirem S, Raffenne J, Negrão M, Albuquerque M, Bedossa P, Godinho Ferreira M, Ait Si Ali S, Fior R, Paradis V.

Liver Int. 2020 Jan 13. doi: 10.1111/liv.14381. [Epub ahead of print]


BEPO®: Bioresorbable diblock mPEG-PDLLA and triblock PDLLA-PEG-PDLLA based in situ forming depots with flexible drug delivery kinetics modulation.

Roberge C, Cros JM, Serindoux J, Cagnon ME, Samuel R, Vrlinic T, Berto P, Rech A, Richard J, Lopez-Noriega A.

J Control Release. 2020 Jan 10;319:416-427. doi: 10.1016/j.jconrel.2020.01.022. [Epub ahead of print]


The postoperative occurrence or worsening of diabetes mellitus may increase the risk of recurrence in resected pancreatic neuroendocrine tumors.

de Mestier L, Védie AL, Faron M, Cros J, Rebours V, Hentic O, Do Cao C, Bardet P, Lévy P, Sauvanet A, Ruszniewski P, Hammel P.

Neuroendocrinology. 2019 Dec 3. doi: 10.1159/000505158. [Epub ahead of print]


Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial.

Hammel P, Fabienne P, Mineur L, Metges JP, Andre T, De La Fouchardiere C, Louvet C, El Hajbi F, Faroux R, Guimbaud R, Tougeron D, Bouche O, Lecomte T, Rebischung C, Tournigand C, Cros J, Kay R, Hamm A, Gupta A, Bachet JB, El Hariry I.

Eur J Cancer. 2020 Jan;124:91-101. doi: 10.1016/j.ejca.2019.10.020. Epub 2019 Nov 21.


hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 Status.

Raffenne J, Nicolle R, Puleo F, Le Corre D, Boyez C, Marechal R, Emile JF, Demetter P, Bardier A, Laurent-Puig P, de Mestier L, Paradis V, Couvelard A, VanLathem JL, MacKey JR, Bachet JB, Svrcek M, Cros J.

Cancers (Basel). 2019 Nov 18;11(11). pii: E1808. doi: 10.3390/cancers11111808.


Prognostic Factors of Acinar Cell Carcinomas: A Study of 44 Patients.

Egal A, Cros J, Svrcek M, Chiche L, Belleannee G, Poizat F, Jouffret L, Maire F, de Mestier L, Hammel P.

Pancreas. 2019 Nov/Dec;48(10):1393-1396. doi: 10.1097/MPA.0000000000001440.


ASO Author Reflections: What Will Be the Future of IPMN Management?

Gaujoux S, Cros J.

Ann Surg Oncol. 2019 Dec;26(Suppl 3):743-744. doi: 10.1245/s10434-019-07858-y. Epub 2019 Sep 24. No abstract available.


High Positive Correlations between ANRIL and p16-CDKN2A/p15-CDKN2B/p14-ARF Gene Cluster Overexpression in Multi-Tumor Types Suggest Deregulated Activation of an ANRIL-ARF Bidirectional Promoter.

Drak Alsibai K, Vacher S, Meseure D, Nicolas A, Lae M, Schnitzler A, Chemlali W, Cros J, Longchampt E, Cacheux W, Pignot G, Callens C, Pasmant E, Allory Y, Bieche I.

Noncoding RNA. 2019 Aug 21;5(3). pii: E44. doi: 10.3390/ncrna5030044.


Familial pancreatic adenocarcinoma: A retrospective analysis of germline genetic testing in a French multicentre cohort.

Schwartz M, Korenbaum C, Benfoda M, Mary M, Colas C, Coulet F, Parrin M, Jonveaux P, Ingster O, Granier S, De Mestier L, Cros J, Riffault A, Muller M, Levy P, Rebours V, Greenhalf W, Soufir N, Hammel P.

Clin Genet. 2019 Dec;96(6):579-584. doi: 10.1111/cge.13629. Epub 2019 Sep 3.


Extended Laparoscopic Central Pancreatectomy with Clamping of the Mesentericoportal Vein and Resection of the Splenic Vessels for a Large Solid Pseudopapillary Tumor.

Dokmak S, Aussilhou B, Paci M, Ftériche FS, Cros J, Maire F, Soubrane O, Sauvanet A.

Ann Surg Oncol. 2019 Oct;26(11):3709-3710. doi: 10.1245/s10434-019-07689-x. Epub 2019 Aug 12.


Continuous hemoglobin and plethysmography variability index monitoring can modify blood transfusion practice and is associated with lower mortality.

Cros J, Dalmay F, Yonnet S, Charpentier M, Tran-Van-Ho J, Renaudeau F, Drouet A, Guilbaut P, Marin B, Nathan N.

J Clin Monit Comput. 2019 Aug 3. doi: 10.1007/s10877-019-00367-z. [Epub ahead of print]


Lesion-by-lesion correlation between uptake at FDG PET and the Ki67 proliferation index in resected pancreatic neuroendocrine tumors.

de Mestier L, Armani M, Cros J, Hentic O, Rebours V, Cadiot G, Sauvanet A, Couvelard A, Lebtahi R, Ruszniewski P.

Dig Liver Dis. 2019 Dec;51(12):1720-1724. doi: 10.1016/j.dld.2019.06.022. Epub 2019 Jul 23.


Endoscopic, transanal, laparoscopic, and transabdominal management of rectal neuroendocrine tumors.

de Mestier L, Lorenzo D, Fine C, Cros J, Hentic O, Walter T, Panis Y, Couvelard A, Cadiot G, Ruszniewski P.

Best Pract Res Clin Endocrinol Metab. 2019 Oct;33(5):101293. doi: 10.1016/j.beem.2019.101293. Epub 2019 Jul 9. Review.


Pancreatic Cancer Organoids for Determining Sensitivity to Bromodomain and Extra-Terminal Inhibitors (BETi).

Bian B, Juiz NA, Gayet O, Bigonnet M, Brandone N, Roques J, Cros J, Wang N, Dusetti N, Iovanna J.

Front Oncol. 2019 Jun 5;9:475. doi: 10.3389/fonc.2019.00475. eCollection 2019.


Kras and Lkb1 mutations synergistically induce intraductal papillary mucinous neoplasm derived from pancreatic duct cells.

Collet L, Ghurburrun E, Meyers N, Assi M, Pirlot B, Leclercq IA, Couvelard A, Komuta M, Cros J, Demetter P, Lemaigre FP, Borbath I, Jacquemin P.

Gut. 2019 Jun 1. pii: gutjnl-2018-318059. doi: 10.1136/gutjnl-2018-318059. [Epub ahead of print]


Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor.

de Mestier L, Walter T, Evrard C, de Boissieu P, Hentic O, Cros J, Tougeron D, Lombard-Bohas C, Rebours V, Hammel P, Ruszniewski P.

Neuroendocrinology. 2020;110(1-2):83-91. doi: 10.1159/000500862. Epub 2019 May 10.


Digestive system mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN).

de Mestier L, Cros J.

Ann Endocrinol (Paris). 2019 Jun;80(3):172-173. doi: 10.1016/j.ando.2019.04.006. Epub 2019 Apr 11. No abstract available.


GNAS but Not Extended RAS Mutations Spectrum are Associated with a Better Prognosis in Intraductal Pancreatic Mucinous Neoplasms.

Gaujoux S, Parvanescu A, Cesaretti M, Silve C, Bieche I, Rebours V, Lévy P, Sauvanet A, Cros J.

Ann Surg Oncol. 2019 Aug;26(8):2640-2650. doi: 10.1245/s10434-019-07389-6. Epub 2019 Apr 25.


Appropriateness of pancreatic resection in high-risk individuals for familial pancreatic ductal adenocarcinoma: a patient-level meta-analysis and proposition of the Beaujon score.

de Mestier L, Muller M, Cros J, Vullierme MP, Vernerey D, Maire F, Dokmak S, Rebours V, Sauvanet A, Lévy P, Hammel P.

United European Gastroenterol J. 2019 Apr;7(3):358-368. doi: 10.1177/2050640618824910. Epub 2019 Jan 12.


Non-branched microcysts of the pancreas on MR imaging of patients with pancreatic tumors who had pancreatectomy may predict the presence of pancreatic intraepithelial neoplasia (PanIN): a preliminary study.

Vullierme MP, Menassa L, Couvelard A, Rebours V, Maire F, Ibrahim T, Cros J, Ruszniewski P, Sauvanet A, Levy P, Soyer P, Vilgrain V.

Eur Radiol. 2019 Nov;29(11):5731-5741. doi: 10.1007/s00330-019-06154-3. Epub 2019 Apr 10.


Reply to Dr Raghuraman.

Cros J.

Reg Anesth Pain Med. 2019 Apr;44(4):526-527. doi: 10.1136/rapm-2018-100227. No abstract available.


Can we classify ampullary tumours better? Clinical, pathological and molecular features. Results of an AGEO study.

Perkins G, Svrcek M, Bouchet-Doumenq C, Voron T, Colussi O, Debove C, Merabtene F, Dumont S, Sauvanet A, Hammel P, Cros J, André T, Bachet JB, Bardier A, Douard R, Meatchi T, Peschaud F, Emile JF, Cojean-Zelek I, Laurent-Puig P, Taieb J.

Br J Cancer. 2019 Apr;120(7):697-702. doi: 10.1038/s41416-019-0415-8. Epub 2019 Mar 6.


O6-methylguanine-DNA methyltransferase (MGMT) status in neuroendocrine tumors: a randomized phase II study (MGMT-NET).

Lemelin A, Barritault M, Hervieu V, Payen L, Péron J, Couvelard A, Cros J, Scoazec JY, Bin S, Villeneuve L, Lombard-Bohas C, Walter T; MGMT-NET investigators.

Dig Liver Dis. 2019 Apr;51(4):595-599. doi: 10.1016/j.dld.2019.02.001. Epub 2019 Feb 14.


Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses.

de Mestier L, Walter T, Brixi H, Evrard C, Legoux JL, de Boissieu P, Hentic O, Cros J, Hammel P, Tougeron D, Lombard-Bohas C, Rebours V, Ruszniewski P, Cadiot G.

Neuroendocrinology. 2019;108(4):343-353. doi: 10.1159/000498887. Epub 2019 Feb 13.


Effects of Dietary Protein and Fat Content on Intrahepatocellular and Intramyocellular Lipids during a 6-Day Hypercaloric, High Sucrose Diet: A Randomized Controlled Trial in Normal Weight Healthy Subjects.

Surowska A, Jegatheesan P, Campos V, Marques AS, Egli L, Cros J, Rosset R, Lecoultre V, Kreis R, Boesch C, Pouymayou B, Schneiter P, Tappy L.

Nutrients. 2019 Jan 21;11(1). pii: E209. doi: 10.3390/nu11010209.


Prognostic Biomarkers in Pancreatic Cancer: Avoiding Errata When Using the TCGA Dataset.

Nicolle R, Raffenne J, Paradis V, Couvelard A, de Reynies A, Blum Y, Cros J.

Cancers (Basel). 2019 Jan 21;11(1). pii: E126. doi: 10.3390/cancers11010126.


The extra-splanchnic fructose escape after ingestion of a fructose-glucose drink: An exploratory study in healthy humans using a dual fructose isotope method.

Francey C, Cros J, Rosset R, Crézé C, Rey V, Stefanoni N, Schneiter P, Tappy L, Seyssel K.

Clin Nutr ESPEN. 2019 Feb;29:125-132. doi: 10.1016/j.clnesp.2018.11.008. Epub 2018 Nov 27.


Impact of sleep restriction on metabolic outcomes induced by overfeeding: a randomized controlled trial in healthy individuals.

Cros J, Pianezzi E, Rosset R, Egli L, Schneiter P, Cornette F, Pouymayou B, Heinzer R, Tappy L, Kreis R, Boesch C, Haba-Rubio J, Lecoultre V.

Am J Clin Nutr. 2019 Jan 1;109(1):17-28. doi: 10.1093/ajcn/nqy215.


Endothelial fatty liver binding protein 4: a new targetable mediator in hepatocellular carcinoma related to metabolic syndrome.

Laouirem S, Sannier A, Norkowski E, Cauchy F, Doblas S, Rautou PE, Albuquerque M, Garteiser P, Sognigbé L, Raffenne J, van Beers BE, Soubrane O, Bedossa P, Cros J, Paradis V.

Oncogene. 2019 Apr;38(16):3033-3046. doi: 10.1038/s41388-018-0597-1. Epub 2018 Dec 21.


Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.

Neuzillet C, Tijeras-Raballand A, Ragulan C, Cros J, Patil Y, Martinet M, Erkan M, Kleeff J, Wilson J, Apte M, Tosolini M, Wilson AS, Delvecchio FR, Bousquet C, Paradis V, Hammel P, Sadanandam A, Kocher HM.

J Pathol. 2019 May;248(1):51-65. doi: 10.1002/path.5224. Epub 2019 Feb 22.


Proteomic Landscape of Cholangiocarcinomas Reveals Three Different Subgroups According to Their Localization and the Aspect of Non-Tumor Liver.

Le Faouder J, Gigante E, Léger T, Albuquerque M, Beaufrère A, Soubrane O, Dokmak S, Camadro JM, Cros J, Paradis V.

Proteomics Clin Appl. 2019 Jan;13(1):e1800128. doi: 10.1002/prca.201800128. Epub 2018 Dec 19.


Sporadic pancreatic neuroendocrine tumor: Surgery of the primary tumor.

Deguelte S, de Mestier L, Hentic O, Cros J, Lebtahi R, Hammel P, Kianmanesh R.

J Visc Surg. 2018 Dec;155(6):483-492. doi: 10.1016/j.jviscsurg.2018.08.010. Epub 2018 Nov 15. Review.


Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma.

Job S, Draskovic I, Burnichon N, Buffet A, Cros J, Lépine C, Venisse A, Robidel E, Verkarre V, Meatchi T, Sibony M, Amar L, Bertherat J, de Reyniès A, Londoño-Vallejo A, Favier J, Castro-Vega LJ, Gimenez-Roqueplo AP.

Clin Cancer Res. 2019 Jan 15;25(2):760-770. doi: 10.1158/1078-0432.CCR-18-0139. Epub 2018 Oct 9.


Competitive Testing of the WHO 2010 versus the WHO 2017 Grading of Pancreatic Neuroendocrine Neoplasms: Data from a Large International Cohort Study.

Rindi G, Klersy C, Albarello L, Baudin E, Bianchi A, Buchler MW, Caplin M, Couvelard A, Cros J, de Herder WW, Delle Fave G, Doglioni C, Federspiel B, Fischer L, Fusai G, Gavazzi F, Hansen CP, Inzani F, Jann H, Komminoth P, Knigge UP, Landoni L, La Rosa S, Lawlor RT, Luong TV, Marinoni I, Panzuto F, Pape UF, Partelli S, Perren A, Rinzivillo M, Rubini C, Ruszniewski P, Scarpa A, Schmitt A, Schinzari G, Scoazec JY, Sessa F, Solcia E, Spaggiari P, Toumpanakis C, Vanoli A, Wiedenmann B, Zamboni G, Zandee WT, Zerbi A, Falconi M.

Neuroendocrinology. 2018;107(4):375-386. doi: 10.1159/000494355. Epub 2018 Oct 9.


Prognostic stratification of resected pancreatic ductal adenocarcinoma: Past, present, and future.

Barhli A, Cros J, Bartholin L, Neuzillet C.

Dig Liver Dis. 2018 Oct;50(10):979-990. doi: 10.1016/j.dld.2018.08.009. Epub 2018 Aug 20. Review.


Breath acetone as a marker of energy balance: an exploratory study in healthy humans.

Bovey F, Cros J, Tuzson B, Seyssel K, Schneiter P, Emmenegger L, Tappy L.

Nutr Diabetes. 2018 Sep 10;8(1):50. doi: 10.1038/s41387-018-0058-5.


Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features.

Puleo F, Nicolle R, Blum Y, Cros J, Marisa L, Demetter P, Quertinmont E, Svrcek M, Elarouci N, Iovanna J, Franchimont D, Verset L, Galdon MG, Devière J, de Reyniès A, Laurent-Puig P, Van Laethem JL, Bachet JB, Maréchal R.

Gastroenterology. 2018 Dec;155(6):1999-2013.e3. doi: 10.1053/j.gastro.2018.08.033. Epub 2018 Aug 27.


PD-1, PD-L1, and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications.

Luchini C, Cros J, Pea A, Pilati C, Veronese N, Rusev B, Capelli P, Mafficini A, Nottegar A, Brosens LAA, Noë M, Offerhaus GJA, Chianchiano P, Riva G, Piccoli P, Parolini C, Malleo G, Lawlor RT, Corbo V, Sperandio N, Barbareschi M, Fassan M, Cheng L, Wood LD, Scarpa A.

Hum Pathol. 2018 Nov;81:157-165. doi: 10.1016/j.humpath.2018.07.006. Epub 2018 Jul 18.


Acceleration of the learning curve for mastering basic critical care echocardiography using computerized simulation.

Vignon P, Pegot B, Dalmay F, Jean-Michel V, Bocher S, L'her E, Cros J, Prat G; EchoSimu Group.

Intensive Care Med. 2018 Jul;44(7):1097-1105. doi: 10.1007/s00134-018-5248-z. Epub 2018 Jun 21.


Array comparative genomic hybridization identifies high level of PI3K/Akt/mTOR pathway alterations in anal cancer recurrences.

Cacheux W, Tsantoulis P, Briaux A, Vacher S, Mariani P, Richard-Molard M, Buecher B, Richon S, Jeannot E, Lazartigues J, Rouleau E, Mariani O, El Alam E, Cros J, Roman-Roman S, Mitry E, Girard E, Dangles-Marie V, Lièvre A, Bièche I.

Cancer Med. 2018 May 26. doi: 10.1002/cam4.1533. [Epub ahead of print]


The Impact of Caloric and Non-Caloric Sweeteners on Food Intake and Brain Responses to Food: A Randomized Crossover Controlled Trial in Healthy Humans.

Crézé C, Candal L, Cros J, Knebel JF, Seyssel K, Stefanoni N, Schneiter P, Murray MM, Tappy L, Toepel U.

Nutrients. 2018 May 15;10(5). pii: E615. doi: 10.3390/nu10050615.


Pectoral I Block Does Not Improve Postoperative Analgesia After Breast Cancer Surgery: A Randomized, Double-Blind, Dual-Centered Controlled Trial.

Cros J, Sengès P, Kaprelian S, Desroches J, Gagnon C, Labrunie A, Marin B, Crépin S, Nathan N, Beaulieu P.

Reg Anesth Pain Med. 2018 Aug;43(6):596-604. doi: 10.1097/AAP.0000000000000779.


In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinoma.

Dayot S, Speisky D, Couvelard A, Bourgoin P, Gratio V, Cros J, Rebours V, Sauvanet A, Bedossa P, Paradis V, Ruszniewski P, Couvineau A, Voisin T.

Oncotarget. 2018 Jan 9;9(6):6952-6967. doi: 10.18632/oncotarget.24084. eCollection 2018 Jan 23.


Preoperative imaging and pathologic classification for pancreatic neuroendocrine tumors.

Deguelte S, de Mestier L, Hentic O, Cros J, Lebtahi R, Hammel P, Kianmanesh R.

J Visc Surg. 2018 Apr;155(2):117-125. doi: 10.1016/j.jviscsurg.2017.12.008. Epub 2018 Feb 12. Review.


Contrast harmonic EUS for the prediction of pancreatic neuroendocrine tumor aggressiveness (with videos).

Palazzo M, Napoléon B, Gincul R, Pioche M, Pujol B, Lefort C, Fumex F, Hautefeuille V, Fabre M, Cros J, Felce M, Couvelard A, Sauvanet A, Lévy P, Ruszniewski P, Palazzo L.

Gastrointest Endosc. 2018 Jun;87(6):1481-1488. doi: 10.1016/j.gie.2017.12.033. Epub 2018 Jan 8.


A false postoperative recurrence of intraductal and papillary mucinous neoplasm of the pancreas.

Ahmed O, Pommier R, Cros J, Sauvanet A.

J Visc Surg. 2018 Apr;155(2):165-166. doi: 10.1016/j.jviscsurg.2017.12.011. Epub 2017 Dec 29.


[Molecular characterisation defines several subtypes of pancreatic ductal adenocarcinoma].

Raffenne J, Cros J.

Bull Cancer. 2018 Jan;105(1):55-62. doi: 10.1016/j.bulcan.2017.11.010. Epub 2017 Dec 19. Review. French.


Robot-Assisted Laparoscopic Fundoplications in Pediatric Surgery: Experience Review.

Binet A, Fourcade L, Amar S, Alzahrani K, Cook AR, Braïk K, Cros J, Longis B, Villemagne T, Lardy H, Ballouhey Q.

Eur J Pediatr Surg. 2019 Apr;29(2):173-178. doi: 10.1055/s-0037-1615279. Epub 2017 Dec 19.


Gastric stump carcinoma as a long-term complication of pancreaticoduodenectomy: report of two cases and review of the English literature.

Bouquot M, Dokmak S, Barbier L, Cros J, Levy P, Sauvanet A.

BMC Gastroenterol. 2017 Nov 22;17(1):117. doi: 10.1186/s12876-017-0682-x. Review.


Prevalence of Microsatellite Instability in Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Lupinacci RM, Goloudina A, Buhard O, Bachet JB, Maréchal R, Demetter P, Cros J, Bardier-Dupas A, Collura A, Cervera P, Scriva A, Dumont S, Hammel P, Sauvanet A, Louvet C, Delpéro JR, Paye F, Vaillant JC, André T, Closset J, Emile JF, Van Laethem JL, Jonchère V, Abd Alsamad I, Antoine M, Rodenas A, Fléjou JF, Dusetti N, Iovanna J, Duval A, Svrcek M.

Gastroenterology. 2018 Mar;154(4):1061-1065. doi: 10.1053/j.gastro.2017.11.009. Epub 2017 Nov 20.


Supplemental Content

Support Center